Following a discussion about when it is most appropriate to alter a patient’s treatment, Drs. Lublin, Coyle, Markowitz, and Riley explore the variety of options available in multiple sclerosis and discuss their considerations for drug sequencing and concerns for adverse events.
Drs. Lublin, Markowitz, and Riley comment on how progress in delaying or preventing disability in patients with multiple sclerosis is related to improvements in findings of more recent clinical trials.
Overcoming divisiveness its ranks over the politically charged issue of what to do about gun violence, the AMA House of Delegates today overwhelmingly endorsed a measure calling gun violence a public health crisis. The AMA will lobby to end a federal ban on gun violence research.
Three types of amoebae that live in fresh water can migrate from the nose to the brain causing Primary Amoebic Meningioencephalitis, the AMA warns. With fast treatment it can be cured, otherwise it is fatal.
It was not that long ago when doctors would sometimes not discuss the diagnosis of multiple sclerosis with their patients. Now not only is it a condition they can diagnose but treatment is also progressing by leaps and bounds.
A patient who has had a stroke does not have to have another one. The challenge for physicians is getting that patient to take the medications prescribed. A UK study defines the barriers to compliance.